Evaluation of an increased strut porosity silicate-substituted calcium phosphate, SiCaP  EP, as a synthetic bone graft substitute in spinal fusion surgery: a prospective, open-label study

ConclusionsEnhanced strut porosity SiCaP EP provided high (month 12: 86.3%) spinal fusion success rates in PLF surgery. Fusion success was associated with improved clinical outcomes in patients within 12  months, relative to baseline.ClinicalTrials.gov identifierNCT01452022Graphical abstractThese slides can be retrieved under Electronic Supplementary Material.
Source: European Spine Journal - Category: Orthopaedics Source Type: research